May 18, 2020
8:5
For every 5 shares held, investors received 8. The price per share adjusted from $29.15 to $18.22.
The split itself did not change the total investment value.
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A (SZSE:300497) operates in the Pharmaceuticals: major industry.
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A company overviewJiangxi Fushine Pharmaceutical Co., Ltd. Class A's most recent stock split was on May 18, 2020. It was a 8-for-5 forward split, so shareholders received 8 shares for every 5 they held.
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A (SZSE:300497) has split its stock 4 times: a 3-for-2 split on September 23, 2016, a 2-for-1 split on July 3, 2018, a 6-for-5 split on June 6, 2019, and a 8-for-5 split on May 18, 2020.
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A has split its stock 4 times. This history records 4 forward splits between September 23, 2016 and May 18, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Jiangxi Fushine Pharmaceutical Co., Ltd. Class A's 8-for-5 split on May 18, 2020, every 5 shares became 8 shares.
Jiangxi Fushine Pharmaceutical Co., Ltd. Class A has not announced a new split in our records. Its most recent split was on May 18, 2020, 6 years ago. Companies announce splits in advance, and any new SZSE:300497 split will appear on this page.
Already premium?